Otto Mølby Henriksen

5PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Medical infection agents (incl. prions)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 10, 2026
[18F]FET PET imaging for early response assessment of bevacizumab in recurrent glioblastoma.

|Feb 13, 2026
First Clinical Experiences with the Ultra-Fast Time-of-Flight BIOGRAPH One Next-Generation Hybrid PET/MRI System.

Otto M Henriksen, Kirsten Korsholm, Annika Loft

|Jan 11, 2026
Simultaneous multiple post-labelling delay ASL MRI and [18F]FDG PET in a mixed memory clinic population and healthy controls.

Otto M Henriksen, Oriol P Calvo, Frederik J Bruun

|Dec 12, 2024
Added prognostic value of DCE blood volume imaging in patients with suspected recurrent or residual glioblastoma-A hybrid [18F]FET PET/MRI study.

Otto Mølby Henriksen, Aida Muhic, Michael Juncker Lundemann

|Dec 11, 2024
Magnetic resonance imaging and o-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography for early response assessment of nivolumab and bevacizumab in patients with recurrent high-grade astrocytic glioma.

Otto Mølby Henriksen, Simone Maarup, Benedikte Hasselbalch

Pageof 1

Frequent Collaborators

3 joint publications

Ian Law

2 joint publications

Hans Skovgaard Poulsen

1 joint publications

Oriol P Calvo

1 joint publications

Frederik J Bruun